Committee Composition

  Audit Nominating and Governance Compensation
Jack Goldstein, Ph.D Chairman of the Board Member of Audit Committee Member of Nominating and Governance Committee Member of Compensation Committee
Scott Cormack      
Neil James Clendeninn, Ph.D, MD   Member of Nominating and Governance Committee Committee Chair for Compensation Committee
Martin Mattingly, PharmD Member of Audit Committee   Member of Compensation Committee
Stewart Parker Member of Audit Committee Committee Chair for Nominating and Governance Committee  
Director

Stewart Parker has served as a director of the Company since March 2010. She served as the CEO of The Infectious Disease Research Institute (IDRI), a not for profit global health research institute from March 2011 to January 2014. Ms. Parker managed the formation of Targeted Genetics and served as President, Chief Executive Officer and a director of Targeted Genetics since its spinout from Immunex in 1992 to 2008. She served in various capacities at Immunex from August 1981 through December 1991, most recently as vice president, corporate development. Ms. Parker also served as president and a director of Receptech Corporation, a company formed by Immunex in 1989 to accelerate the development of soluble cytokine receptor products, from February 1991 to January 1993. She has served on the board of directors and the executive committee of BIO, the primary trade organization for the biotechnology industry, and as a director of several privately held companies. Ms. Parker received her B.A. and M.B.A. from the University of Washington.


David Smith Committee Chair for Audit Committee Member of Nominating and Governance Committee  
Chair of the Board = Chair of the Board Committee Chair = Chair Committee Member = Member